| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/06/2005 | EP1549316A1 INHIBITORS OF TFG&bgr; |
| 07/06/2005 | EP1373256B1 Ccr5 antagonists useful for treating aids |
| 07/06/2005 | EP1212320B1 Phenylpiperazines as serotonin reuptake inhibitors |
| 07/06/2005 | EP1140909B1 Novel inhibitors of farnesyl-protein transferase |
| 07/06/2005 | EP1044001B1 Integrin receptor antagonists |
| 07/06/2005 | EP0776327B1 New multimerizing agents |
| 07/06/2005 | CN1636154A Di-substituted iminoheterocyclic compounds |
| 07/06/2005 | CN1636011A Succinoylamino lactams as inhibitors and as a beta protein production |
| 07/06/2005 | CN1636001A 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators |
| 07/06/2005 | CN1636000A 5-substituted arylpyrimidines |
| 07/06/2005 | CN1635891A Tetrahydroquinoline analogues as muscarinic agonists |
| 07/06/2005 | CN1635890A Neuroprotective 2-pyridinamine compositions and related methods |
| 07/06/2005 | CN1635885A Improvement of nitric oxide synthase activity by using substituted indole compound |
| 07/06/2005 | CN1635877A Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 07/06/2005 | CN1634918A 2-pyridyl-1H-benzimidazole-4-amide derivatives |
| 07/06/2005 | CN1634893A 4, 5-disubstituted-1, 8-naphthoyl imide compounds and use thereof |
| 07/06/2005 | CN1209368C Novel acetamide derivative and use thereof |
| 07/06/2005 | CN1209362C Tetrazolyl-phenyl acetamide glucokinase activators |
| 07/06/2005 | CN1209361C Hydantoin-containing glucokinase activators |
| 07/06/2005 | CN1209360C 16-halogen-epothilone derivatives, process for producing them and their pharmaceutical use |
| 07/06/2005 | CN1209359C Novel dihydric indole compound, their preparation process and medicinal compositions containing them |
| 07/06/2005 | CN1209358C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 07/06/2005 | CN1209351C N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as CCR3 receptor antagonists |
| 07/06/2005 | CN1209016C Fungicides |
| 07/05/2005 | US6914160 Oxytocin inhibitors |
| 07/05/2005 | US6914069 Pharmaceutically active compounds and methods of use |
| 07/05/2005 | US6914066 1,2-annelated quinoline derivatives |
| 07/05/2005 | US6914062 Pyrazinone derivatives |
| 07/05/2005 | US6914058 1-(p-(thiomorpholino)phenyl)-1,2,3-triazole derivatives |
| 07/05/2005 | CA2309485C New 4-arylpiperidine derivatives for the treatment of pruritus |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 06/30/2005 | WO2005059107A2 Chemokine receptor binding compounds |
| 06/30/2005 | WO2005059037A1 Reagent for detecting an analyte |
| 06/30/2005 | WO2005058920A1 Regiospecific synthesis of nicotine derivatives |
| 06/30/2005 | WO2005058885A2 Piperidine derivatives and their use as glycine transporter inhibitors |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058883A1 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 06/30/2005 | WO2005058882A1 Compounds having morpholinyl and piperidinyl groups for use as glyt1 and glyt2 inhibitors |
| 06/30/2005 | WO2005058877A1 Novel chelating agents and highly luminescent and stable chelates and their use |
| 06/30/2005 | WO2005058876A1 Pyrazine derivatives as effective compounds against infectious diseases |
| 06/30/2005 | WO2005058874A1 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 06/30/2005 | WO2005058873A1 Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 06/30/2005 | WO2005058872A1 Crystalline forms of (+)- and (-)-erythro-mefloquine hydrochloride |
| 06/30/2005 | WO2005058871A1 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 06/30/2005 | WO2005058870A1 Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication |
| 06/30/2005 | WO2005058869A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 06/30/2005 | WO2005058868A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 06/30/2005 | WO2005058857A1 Tetronic and tetramic acids as inhibitors of beta-secrease |
| 06/30/2005 | WO2005058843A1 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/30/2005 | WO2005058841A2 Hiv protease inhibiting compounds |
| 06/30/2005 | WO2005058837A1 Benzazepine derivatives as histamine h3 antagonists |
| 06/30/2005 | WO2005058836A1 Insecticidal spiroindane derivatives |
| 06/30/2005 | WO2005058834A2 Quinolines useful in treating cardiovascular disease |
| 06/30/2005 | WO2005058833A1 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 06/30/2005 | WO2005058832A1 Diacylhydrazine derivatives |
| 06/30/2005 | WO2005058830A1 Novel herbicides |
| 06/30/2005 | WO2005058824A2 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprote in b |
| 06/30/2005 | WO2005058822A1 Substituted amino-cycloalkanes |
| 06/30/2005 | WO2005058821A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 06/30/2005 | WO2005058817A1 Prolinylarylacetamides |
| 06/30/2005 | WO2005058311A1 Heterocyclic aspartyl protease inhibitors |
| 06/30/2005 | WO2005058037A1 Picolinylpyrazoles as herbicides |
| 06/30/2005 | WO2005058035A1 Use of (3-(1-(3-phenyl-propenyl)-piperidin-4-yl)-2,3-dihydro-indol-1-yl)-(pyridin-4-yl)-methanone derivatives and related compounds as insecticides |
| 06/30/2005 | WO2005035504A3 5-h -benzo [d] naphth [2, 1-b] azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 06/30/2005 | WO2005032493A8 Amide compounds as ion channel ligands and uses thereof |
| 06/30/2005 | WO2005032484A3 Alkoxy substituted imidazoquinolines |
| 06/30/2005 | WO2005020899A3 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 06/30/2005 | WO2004089890A3 Process and intermediates for preparing benzazepines |
| 06/30/2005 | WO2004055006A8 Novel compounds having selective inhibiting effect at gsk3 |
| 06/30/2005 | WO2004055005A8 Novel compounds having selective inhibiting effect at gsk3 |
| 06/30/2005 | WO2002058698A8 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 06/30/2005 | US20050143578 Compounds and methods |
| 06/30/2005 | US20050143539 Polymerizable composition with free radicals and by controlling polymerization |
| 06/30/2005 | US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 06/30/2005 | US20050143447 Mixing at least one nonaqueous, pharmaceutically acceptable solvent and a taxane compound |
| 06/30/2005 | US20050143440 Excellent hypoglycemic agents for treating hyperglycemia, dyslipidemia, hypercholesterolemia, noninsulin-dependent type II diabetes, obesity, glucose intolerance, cardiovascular diabetic complications; reduced side effects due to absence of serotonin reuptake inhibition; imidazoline receptor pathologies |
| 06/30/2005 | US20050143439 1-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives |
| 06/30/2005 | US20050143438 N3 alkylated benzimidazole derivatives as MEk inhibitors |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143423 Antiulcer; antisecretory; solubility, bioavailability; slow hydrolysis; full inhibition of acid secretion in oral therapy by prolonged presence in body; 1-(carboxythiophenesulfonyl)- 2-(substituted pyridylmethylsulfinyl) benzimidazoles; also with LANSOPRAZOLE, OMEPRAZOLE, PANTOPRAZOLE, or RABEPRAZOLE |
| 06/30/2005 | US20050143422 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/30/2005 | US20050143419 Guanidine and amidine derivatives as factor Xa inhibitors |
| 06/30/2005 | US20050143418 Pesticidal heterocycles |
| 06/30/2005 | US20050143407 Process for porducing quinolonecarboxylic acid derivative |
| 06/30/2005 | US20050143405 Dipeptidyl peptidase inhibitors that lower plasma glucose; treatment and prophylaxis of diabetes, non-insulin dependent diabetes; 2-amino-3aminomethyl-4-phenylpyridines |
| 06/30/2005 | US20050143403 Substituted pyrimidinones and pyrimidinthiones |
| 06/30/2005 | US20050143390 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/30/2005 | US20050143387 Preserving cosmetic, household or technical products, use in paper treatment liquors, printing thickeners, printing thickeners of starch or cellulose derivatives and paints |
| 06/30/2005 | US20050143375 Imidazole derivatives |
| 06/30/2005 | US20050143372 Compounds, pharmaceutical compositions and methods of use therefor |
| 06/30/2005 | US20050143318 ((1R)-2-indol-3-yl-1-{N-[1-(2-oxo-1-phenyl-2-pyrrolidinylethyl)imidazol-4-yl]carbamoyl)ethyl)-2-[(tert-butoxy)carbonylamino]-2-methylpropanamide; combinded with bone-antiresorptive agent selected from selective estrogen receptor modulators, bisphosphonates, calcitonin, and PTH; carrieres, excipients |
| 06/30/2005 | US20050143316 Hepatitis C virus inhibitors |
| 06/30/2005 | US20050142614 Methods for ligand discovery |
| 06/30/2005 | DE10354584A1 Kationische Diaminopyrazole, ein Verfahren zu deren Herstellung und diese Verbindungen enthaltende Färbemittel Cationic diaminopyrazoles, a process for their preparation and compositions containing these compounds colorant |
| 06/30/2005 | CA2551944A1 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 06/30/2005 | CA2550074A1 Novel chelating agents and highly luminescent and stable chelates and their use |
| 06/30/2005 | CA2550012A1 Urea derivative, process for producing the same and use |
| 06/30/2005 | CA2549825A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 06/30/2005 | CA2549741A1 Reagent for detecting an analyte |